Aditxt(ADTX.US)

Last Updated 19:00:00 ET
longbridge loading

Aditxt Enacts Reverse Stock Split to Maintain Nasdaq Listing

Tip Ranks·
US
ADTX
-6.46%
US
SBIO
-1.24%
US
XBI
-0.69%
Tip Ranks·
US
ADTX
-6.46%
US
SBIO
-1.24%
US
XBI
-0.69%

Aditxt shares are trading lower after the company announced a 1-for-27 reverse stock split.

benzinga_article·
US
ADTX
-6.46%
benzinga_article·
US
ADTX
-6.46%

Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026 | ADTX Stock News

StockTitan·
US
ADTX
-6.46%
US
IBB
+0.10%
US
BBH
+0.68%
StockTitan·
US
ADTX
-6.46%
US
IBB
+0.10%
US
BBH
+0.68%

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·
US
CNSP
+1.49%
US
CELC
-0.92%
US
APRE
-5.35%
benzinga_article·
US
CNSP
+1.49%
US
CELC
-0.92%
US
APRE
-5.35%

12 Health Care Stocks Moving In Monday's Intraday Session

benzinga_article·
US
CMPX
-1.09%
US
ADGM
-5.46%
US
SCNI
-9.27%
benzinga_article·
US
CMPX
-1.09%
US
ADGM
-5.46%
US
SCNI
-9.27%

Aditxt shares are trading lower. Its subsidiary Ignite Proteonomics was included in a study published in the journal npj Precision Oncology.

benzinga_article·
US
ADTX
-6.46%
US
IBBQ
+0.07%
US
XBI
-0.69%
benzinga_article·
US
ADTX
-6.46%
US
IBBQ
+0.07%
US
XBI
-0.69%

Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients | ADTX Stock News

StockTitan·
US
ADTX
-6.46%
StockTitan·
US
ADTX
-6.46%
© 2026 Longbridge｜Disclaimer